Excluding participants with less than 2 years of follow-up between recruitment and cancer diagnosis did not materially alter any of the results, whereas the extension to 5 years slightly attenuated the associations of TG with breast cancer, Lp(a) with prostate cancer, and apo(a) with total cancer mortality. This evidence concerns the gene AOPEP and prostate carcinoma.